USPTO trademark

FIMLUVI

Under examinationUSPTOWord markClass 5

"FIMLUVI" is a word mark owned by Glaxo Group Limited, filed at the USPTO on September 22, 2026. It is under examination and covers class 5 (Pharmaceuticals).

View Glaxo Group Limited portfolioGet this data via the API
Official USPTO record
FIMLUVI trademark as filed
As filed with the USPTO
Status
Under examination
Since September 22, 2026
Filed
September 22, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50122887
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns FIMLUVI

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Glaxo Group Limited

Stevenage, United Kingdom

19,383 trademarks in the portfolioView company

Representative

Christopher M. Hanes

GSK

Goods and services

What the mark covers

The products and services FIMLUVI is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Application filing receipt mailed
  2. New application office supplied data entered
  3. New application entered
FAQ

About FIMLUVI

Who owns the trademark "FIMLUVI"?

The USPTO trademark "FIMLUVI" (application 50122887) is owned by Glaxo Group Limited.

What is the status of "FIMLUVI"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull FIMLUVI and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a0ce63-249a-73be-b63c-9b0d6d26880b
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a0ce63-249a-73be-b63c-9b0d6d26880b",
  "object": "trademark",
  "mark_text": "FIMLUVI",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50122887",
  "filing_date": "2026-09-22",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Glaxo Group Limited",
      "entity_id": "ent_019eb6f6-4cb9-77ae-916f-63b3231a6d3d"
    }
  ]
}